What is Wolff‑Parkinson‑White (WPW) syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Wolff-Parkinson-White (WPW) Syndrome?

WPW syndrome is a congenital cardiac conduction disorder where patients have ventricular pre-excitation visible on their resting ECG (the "WPW pattern") combined with arrhythmia symptoms such as palpitations, syncope, or dizziness. 1

Core Pathophysiology

WPW syndrome results from the presence of one or more accessory pathways (abnormal electrical connections) between the atria and ventricles that bypass the normal atrioventricular (AV) node 1. These pathways:

  • Form during embryologic development when the annulus fibrosus fails to completely separate the atrial and ventricular chambers 2
  • Conduct electrical impulses more rapidly than the normal AV node
  • Create ventricular pre-excitation, producing the characteristic delta wave on ECG (a slurred upstroke of the QRS complex)
  • Allow reentrant tachycardia circuits to form

Key Distinction: Pattern vs. Syndrome

It's critical to understand that not everyone with the WPW pattern has WPW syndrome 3:

  • WPW pattern: Pre-excitation visible on ECG in asymptomatic individuals (affects 0.1-0.3% of the general population) 4
  • WPW syndrome: WPW pattern PLUS symptomatic arrhythmias 3

Clinical Manifestations

Common Arrhythmias

The most frequent arrhythmias in WPW syndrome include 1:

  1. Orthodromic AVRT (most common): Electrical impulse travels down the AV node and returns up the accessory pathway, producing a narrow-complex tachycardia
  2. Antidromic AVRT: Impulse travels down the accessory pathway and returns via the AV node, creating a wide-complex tachycardia with pre-excited QRS
  3. Pre-excited atrial fibrillation: The most dangerous arrhythmia, where AF conducts rapidly down the accessory pathway to the ventricles

Symptoms

Patients typically experience 5:

  • Palpitations
  • Dizziness or lightheadedness
  • Shortness of breath
  • Presyncope or syncope
  • Chest discomfort during tachycardia episodes

Life-Threatening Risk

The most serious complication is sudden cardiac death (SCD), which occurs when atrial fibrillation conducts extremely rapidly over the accessory pathway, degenerating into ventricular fibrillation 1. The 10-year risk of SCD ranges from 0.15% to 0.24%, with highest risk in the first two decades of life 1.

Risk factors for SCD include 1:

  • History of symptomatic tachycardia
  • Multiple accessory pathways
  • Shortest pre-excited R-R interval <250 ms during AF
  • Tragically, SCD may be the first presentation in previously undiagnosed patients 1

Genetic and Familial Considerations

While typically sporadic, WPW shows familial aggregation with siblings of affected individuals having a nearly 4-fold increased risk (though absolute risk remains extremely low at 0.4% of cases being familial) 6. This suggests complex genetic inheritance patterns 6.

Associated Conditions

Most patients have structurally normal hearts, but WPW may occur with 4:

  • Congenital heart disease
  • Systemic diseases
  • Specific syndromes (syndromic WPW)

Diagnostic Approach

The diagnosis requires 1, 3:

  • Resting 12-lead ECG showing the classic triad:
    • Short PR interval (<120 ms)
    • Delta wave (slurred QRS upstroke)
    • Wide QRS complex (>120 ms)
  • Documentation of arrhythmia symptoms to distinguish syndrome from pattern alone
  • Electrophysiologic study for risk stratification, particularly in symptomatic patients or those requiring definitive assessment 3

Common Pitfall: Misdiagnosis of Pre-Excited AF

A critical danger is misdiagnosing pre-excited AF as ventricular tachycardia and administering AV nodal blocking agents (like adenosine, beta-blockers, or calcium channel blockers), which can paradoxically accelerate conduction down the accessory pathway and precipitate ventricular fibrillation 7. Pre-excited AF appears as an irregular wide-complex tachycardia with varying QRS morphology 7.

Impact on Cardiac Function

Beyond arrhythmias, certain accessory pathway locations with overt anterograde conduction can reduce left ventricular systolic performance and exercise capacity due to abnormal ventricular depolarization patterns 4.

References

Research

The Pathophysiology, Diagnosis, and Management of Wolff-Parkinson-White Syndrome in the Neonate.

Advances in neonatal care : official journal of the National Association of Neonatal Nurses, 2021

Research

Wolff-Parkinson-White syndrome: Diagnostic and management strategies.

Cleveland Clinic journal of medicine, 2025

Research

Familial risk of Wolff-Parkinson-White syndrome: a nationwide family study in Sweden.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2025

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.